Skip to main content
SpringerLink
Log in

The early history of psychotherapeutic drugs

  • Review Article
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The four most frequently used groups of drugs in psychiatric therapy are: neuroleptics, antidepressants, anxiolytics, and lithium salts. Their introduction came largely during the past 3 decades. This review summarizes the history of the research that led to their discovery and to the present concept of their modes of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Axelrod JC, Whitby LG, Hertting (1961) Effect of psychotropic drugs on the uptake of 3H-norepinephrine by tissues. Science 133:383–384

    Google Scholar 

  • Baastrup FC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: doubleblind discontinuation in manic-depressive and recurrent depressive disorders. Lancet II:326–330

    Google Scholar 

  • Berger FM (1954) The pharmacological properties of 2-methyl, 2-n propyl-1,3 propandiol dicarbamate (Miltown), a new interneural blocking agent. J Pharmacol Exp Ther 112:413–423

    Google Scholar 

  • Brodie BB, Pletscher AP, Shore PA (1955) Evidence that serotonin has a role in brain function. Science 222:968

    Google Scholar 

  • Cade JEJ (1949) Lithium salts in the treatment of psychic excitement. Med J Aust 36:349–352

    Google Scholar 

  • Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methyl tyramine and nor-metanephrine in mouse brain. Acta Pharmacol 20:140–144

    Google Scholar 

  • Carlsson A, Lindqvist M, Magnusson T (1957) 3,4-dihydroxy phenylalanine and 5-hydroxy tryptophan as reserpine antagonists. Nature 180:1200

    Google Scholar 

  • Chessin M, Kramer ER, Scott CC (1957) Modification of the pharmacology of reserpine and serotonin by iproniazid. J Pharmacol Exp Ther 119:453–460

    Google Scholar 

  • Courvoisier S, Fournier J, Ducrot R, Kolsky M, Koetschet P (1953) Propriétés pharmacodynamiques du chlorhydrate de chloro 3-(dimethyl amino-3′propyl)10 phenothiazine. Arch Int Pharmacodyn 92:305–360

    Google Scholar 

  • Decourt P (1956) Mécanisme d'action de la therapeutique neurobiologene en general, et de chlorpromazine en particular en psychiatrique. Encephale 45:932–944

    Google Scholar 

  • Delay J, Deneker P, Harl JM (1952) Utilisation en therapeutique psychiatrique d'une derivee d'hibernotherapie. Ann Med Psychol 110:112–117

    Google Scholar 

  • Delay J, Laine B, Buisson JF (1952) Note concernant l'action de l'isoamino hydrazide dans le traitement des etats depressifs. Ann Med Psychol 110:689–692

    Google Scholar 

  • Euler US von (1946) A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relation to adrenaline and noradrenaline. Acta Physiol Scand 12:73–97

    Google Scholar 

  • Gay LN, Carliner PL (1949) The prevention and treatment of motion sickness. I. Seasickness. Science 109:359

    Google Scholar 

  • Glowinski J, Axelrod J (1964) Inhibition of uptake of tritiated noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 204:1318–1319

    Google Scholar 

  • Gupta JC, Deb A, Kohali BS (1943) Preliminary observations on the use of Rauwolfia serpentine Benth in the treatment of mental disorders. Indian Med Gaz 78:547–549

    Google Scholar 

  • Hamon J, Paraire J, Velluz J (1952) Remarques sur l'action de 4560 RP sur l'agitation maniaque. Ann Med Psychol 110:332–335

    Google Scholar 

  • Hanlon LW, Romain M, Gilray FJ, Deitrick JE (1949) Lithium chloride as a substitute for sodium chloride in the diet. JAMA 139:688–692

    Google Scholar 

  • Henschule WP (1961) Chlordiazepoxide for calming zoo-animals. J Am Vet Med Assoc 139:996–998

    Google Scholar 

  • Holzbauer M, Vogt M (1956) Depression by reserpine of the noradrenergic concentration in the hypothalamus of the cat. J Neurochem 1:8–11

    Google Scholar 

  • Janssen PAJ (1965) The evolution of the butyrophenones haloperidol and triperidol from meperidine-like 4-phenylpiperidines. Int Rev Neurobiol 8:221–263

    Google Scholar 

  • Johnson FN, Amdisen A (1983) The first era of lithium in medicine: A historical note. Pharmacopsychiatry 16:61–63

    Google Scholar 

  • Kline N (1955) The use of rauwolfia serpentina Benth in neuropsychiatric conditions. Ann New York Acad Sci 59:107–132

    Google Scholar 

  • Kline N (1958) Clinical experience with iproniazid. J Clin Exp Psychopathol 19:(suppl)72–78

    Google Scholar 

  • Kuhn R (1957) Über die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355). Schw Med Wschr 87:1135–1140

    Google Scholar 

  • Laborit H, Huguenard P, Alluaume R (1952) Un nouveau stabilisateur neuro-vegetatif, le 4560 RP. Presse Med 60:206–208

    Google Scholar 

  • Mohler H, Okada I (1977) Benzodiazepine receptor demonstration in the central nervous system. Science 198:849–851

    Google Scholar 

  • Muller JM, Schlitter E, Bein HJ (1952) Reserpin, der sedative Wirkstoff aus Rauwolfia serpentina Benth. Experientia 8:388–391

    Google Scholar 

  • Olsen RW (1982) Drug interaction at the GABA receptor-ionophore complex. Ann Rev Pharmacol Toxicol 22:245–277

    Google Scholar 

  • Petersen PV, Lassen N, Holm T, Kopf R, Nielsen M (1958) Chemical constitution and pharmacological action of some thioxanthene analogues of chlorpromazine and mepazine. Arzneim Forsch 8:395–397

    Google Scholar 

  • Randall LO, Schallek W, Heise GA, Keith EF, Bagdorn RE (1960) The psychosedative properties of methaminodiazepoxide. J Pharmacol Exp Ther 129:163–171

    Google Scholar 

  • Schou M (1959) Lithium in psychiatric therapy. Stock-taking after 10 years. Psychopharmacology 1:65–78

    Google Scholar 

  • Schou M (1983) Lithium perspectives. Neuropsychobiology 10:7–12

    Google Scholar 

  • Selikoff JJ, Robitzak E-H, Orustain GG (1952) Treatment of pulmonary tuberculosis with hydrazine derivatives of isonicotinic acid. JAMA 150:973–982

    Google Scholar 

  • Sen S, Bose KC (1931) Rauwolfia serpentina, a new Indian drug for insanity and high blood pressure. Indian Med World 2:194–198

    Google Scholar 

  • Squires RJ, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266:732–734

    Google Scholar 

  • Swazey JP (1974) Chlorpromazine in psychiatry. MIT Press, Cambridge, Mass

    Google Scholar 

  • Van Rossum J (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn 160:492–494

    Google Scholar 

  • Winter CA (1948) The potentiating effect of antihistaminic drugs upon the sedative action of barbiturates. J Pharmacol Exp Ther 94:7–11

    Google Scholar 

  • Zeller EA, Barsky J, Fouts JH, Kirschheimer WF, Orden JS van (1952) Influence of isonicotinic acid hydrazine and 1-isonicotinyl-2-isopropyl hydrazine in bacterial and mammalian enzymes. Experientia 8:349–350

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Danish School of Pharmacy, Universitetsparken 2, DK-2100, Copenhagen Ø, Denmark

    Erik Jacobsen

Authors
  1. Erik Jacobsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Offprint requests to: Jens Schou, Professor of Pharmacology, University of Copenhagen, 20 Juliane Mariesvej, DK-2100 Copenhagen Ø, Denmark

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobsen, E. The early history of psychotherapeutic drugs. Psychopharmacologia 89, 138–144 (1986). https://doi.org/10.1007/BF00310617

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00310617

Key words

Search

Navigation